Immunocore Holdings (IMCR) Other Working Capital Changes (2024 - 2026)
Immunocore Holdings (IMCR) posted Other Working Capital Changes of -$864000.0 for Q1 2026, up 66.99% sequentially from -$2.6 million in Q4 2025, and down 214.29% YoY from $756000.0 in Q1 2025.
Analysis
Immunocore Holdings (IMCR) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Immunocore Holdings has reported Other Working Capital Changes for 4 years, with the latest figure at -$864000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 214.29% year-over-year to -$864000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 823.63% YoY) and the FY2025 annual result came in at -$2.1 million, down 27.0% from the prior year.
- Other Working Capital Changes improved to -$864000.0 in Q1 2026 per IMCR's latest filing, from -$2.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $27.2 million in Q4 2023 and troughed at -$18.1 million in Q1 2023.
- A 4-year average of $3.6 million and a median of $1.9 million in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 1561.11% in 2025, down 494.77% in 2025.
- Over 4 years, Other Working Capital Changes stood at -$8.7 million in 2023, then soared by 94.92% to -$440000.0 in 2024, then plunged by 494.77% to -$2.6 million in 2025, then jumped by 66.99% to -$864000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$864000.0, -$2.6 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Immunocore Holdings | 1.85 Bn | 965.54 Mn | 114.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -146,000.00 |
| Jun 30, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -144,000.00 |
| Dec 31, 2025 | -144,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | -97,000.00 |
| Jun 30, 2025 | -97,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |